Brief: Baudax Bio Reports Net Income Of $10.03 Per Diluted Share
16/03/2022 12:38
March 16 (Reuters) - Baudax Bio Inc BXRX.O :
* BAUDAX BIO REPORTS 2021 FOURTH QUARTER AND ANNUAL
FINANCIAL
RESULTS
* BAUDAX BIO INC - AS OF DECEMBER 31, 2021, BAUDAX BIO HAD
CASH
AND CASH EQUIVALENTS OF $15.9 MILLION
* BAUDAX BIO INC - REPORTED NET INCOME OF $10.03 PER DILUTED
SHARE, FOR THREE MONTHS ENDED DECEMBER 31, 2021
* BAUDAX BIO INC - IN MARCH 2022, CO IMPLEMENTED PLANS TO
REDUCE
EXPENSES INCLUDING ABOUT 80% REDUCTION IN CO'S WORKFORCE
* BAUDAX BIO INC - SEVERANCE AND OTHER RELATED COSTS DUE TO
REDUCTION IN WORKFORCE ARE ESTIMATED TO BE ABOUT $4 MILLION,
RECOGNIZED PRIMARILY IN Q1
Source text for Eikon: ID:nGNX4RNVdQ
Further company coverage: BXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer